Thyroid dysfunction does not predict mortality in heart failure, finds study

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2020-11-11 10:30 GMT | Update On 2020-11-12 07:47 GMT

UK: Researchers exploring connection between thyroid function and prognosis in CHF (chronic heart failure) patients found that although thyroid dysfunction is associated with poorer survival, it does not predict mortality. The findings of the study are published in the American Journal of Cardiology.

About 10% of the CHF patients have subclinical thyroid dysfunction but evidence on its prognostic significance is conflicting.

Nathan A. Samuel, Hull York Medical School, University of Hull, UK, and colleagues investigated the association between thyroid function and prognosis in a large, well characterized cohort of ambulatory patients with CHF.

Heart failure was defined as signs and symptoms of the disease and either left ventricular systolic dysfunction (LVSD) mild or worse or no LVSD and raised amino-terminal pro-B-type natriuretic peptide (NT-proBNP) levels (>125 ng/L; heart failure with normal ejection fraction [HFnEF]).

Euthyroid state was defined as a thyroid-stimulating hormone (TSH) level between 0.35 and 4.70 mIU/l, hypothyroidism as TSH >4.70 mIU/l, and hyperthyroidism as TSH <0.35 mIU/l.

Also Read: HDL function gets impaired in severe hypothyroidism patients: JCEM Study

Key findings of the study include:

2997 patients had HFrEF and 1995 patients had HFnEF-- 90% patients were euthyroid, 6% were hypothyroid, and 4%were hyperthyroid.
In univariable analysis, both hypothyroid patients (hazard ratio [HR] 1.25) and hyperthyroid patients (HR 1.21) had a greater risk of death compared with euthyroid patients.
There was a U-shaped relation between TSH and outcome.
Increasing TSH was a predictor of mortality in univariable analysis (HR 1.02), but the association disappeared in multivariable analysis.
The three strongest predictors of adverse outcome were increasing age, increasing NT-proBNP, and higher NYHA class.

"Although thyroid dysfunction is associated with worse survival in patients with CHF, it is not an independent predictor of mortality," concluded the authors.

Also Read: Levothyroxine may not improve cardiac function in hypothyroid patients with heart attack: JAMA

The study, "Relation Between Thyroid Function and Mortality in Patients With Chronic Heart Failure," is published in the American Journal of Cardiology.

DOI: https://www.ajconline.org/article/S0002-9149(20)31140-1/fulltext

Article Source : American Journal of Cardiology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Medha Baranwal

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Thyroid dysfunction does not predict mortality in heart failure, finds study

Similar News

Covert brain infarcts and white matter hyperintensities linked to increased fall risks: AHA

Poor Heart-Kidney-Metabolic Health and Genetics May Double Psoriasis Risk, Study Finds

Heart-healthy habits also prevent cancer, Alzheimer’s, COPD, other diseases, Emory study finds

Boehringer Ingelheim, AnGes sign manufacturing agreement for HGF gene therapy product

Rivaroxaban Monotherapy Effective Across Age Groups in Atrial Fibrillation Patients With Stable CAD: AFIRE Trial

More Sit-to-Stand Transitions May Lower Blood Pressure in Postmenopausal Women: Study

Hypertension and Depression Together Amplify Risk of Cardiovascular Disease and Early Death, Finds Study

Finerenone Benefits Consistent Across Diuretic Subgroups in HFmrEF/HFpEF: JAMA